February 28, 2015 7:57 PM ET

Life Sciences Tools and Services

Company Overview of Creganna-Tactx Medical

Company Overview

Creganna-Tactx Medical designs, develops, manufactures, and delivers minimally invasive delivery and access devices. Its products are in a range of MI catheter market segments, including PTCA, PTA, EP, specialty and niche catheters–Atherectomy, CTO, vulnerable plaque, thrombectomy, and GI catheters. The company’s designs and development projects include PTCA and PTA balloon catheters, stent delivery systems, CTO catheters, vulnerable plaque detection catheters, embolic filter device delivery systems, steerable EP catheters and sheaths, Kyphoplasty delivery devices, endoscopic biopsy devices, IVUS and imaging delivery systems, laparoscopic devices, and valve repair/replacement delivery system...

Parkmore West Industrial Estate



Founded in 1980


353 9 175 7801


353 9 175 7850

Key Executives for Creganna-Tactx Medical

Chief Executive Officer
Age: 54
Co-Founder and Non-Executive Director
Co-Founder and Director
Chief Financial Officer and Director
Head of Meridian Technology Development Program
Compensation as of Fiscal Year 2014.

Creganna-Tactx Medical Key Developments

Creganna-Tactx Medical Opens its First Representative Office in China

Creganna-Tactx Medical announced the opening of its first representative office in China. The new office is being established to enable the company build upon its existing presence in the market by forging deeper partnerships with its foreign and domestic customer base in China. The Chinese medical device market continues to grow at 20% per annum and this latest addition to the company's global network reflects the continued commercial opportunity within the region. Located in Shanghai, the office is locally staffed with industry experienced professionals who are expert in all facets of the domestic healthcare market. Along with providing enhanced commercial, technical and customer-service support to the company's customers in China, the team will also assist customers to identify and develop leading products customized to local market requirements.

Creganna-Tactx Medical Announces Management Changes

Creganna-Tactx Medical has announced that Robert B. Hance will join the company as Chief Executive Officer in September 2013, taking over the role from Helen Ryan who has held the position for the last eight years. Robert "Chip" Hance has extensive experience in the medical device sector with more than 23 years at Abbott Laboratories, most recently as President of Abbott Vascular. Over a four year period at Abbott Vascular, Hance led a 9,000 person organisation through a period of significant sales growth from $1.7 billion in 2007 to $3.3 billion in 2011, to command global market leadership in the drug eluting stent market. Helen Ryan will take up a new board role as non-executive director.

Similar Private Companies By Industry

Company Name Region
APC Ltd. Europe
CodeX Discovery Ltd Europe
Zenith Technologies Ltd. Europe
Creganna-Tactx Medical Europe
Microchem Laboratories (Ireland) Ltd. Europe

Recent Private Companies Transactions

October 24, 2014
Precision Wire Components, LLC

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Creganna-Tactx Medical, please visit www.cregannatactx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.